290 related articles for article (PubMed ID: 12837731)
1. Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.
Warhurst DC; Steele JC; Adagu IS; Craig JC; Cullander C
J Antimicrob Chemother; 2003 Aug; 52(2):188-93. PubMed ID: 12837731
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
Fowler VG; Lemnge M; Irare SG; Malecela E; Mhina J; Mtui S; Mashaka M; Mtoi R
J Trop Med Hyg; 1993 Dec; 96(6):337-45. PubMed ID: 8254710
[TBL] [Abstract][Full Text] [Related]
3. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
Manohar S; Khan SI; Rawat DS
Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
5. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
7. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine and Hydroxychloroquine Increase Retinal Pigment Epithelial Layer Permeability.
Korthagen NM; Bastiaans J; van Meurs JC; van Bilsen K; van Hagen PM; Dik WA
J Biochem Mol Toxicol; 2015 Jul; 29(7):299-304. PubMed ID: 25752684
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
[TBL] [Abstract][Full Text] [Related]
11. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2.
Xu C; Zhu L; Chan T; Lu X; Shen W; Madigan MC; Gillies MC; Zhou F
J Pharm Sci; 2016 Feb; 105(2):884-890. PubMed ID: 26429523
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles.
Muga JO; Gathirwa JW; Tukulula M; Jura WGZO
Malar J; 2018 Apr; 17(1):133. PubMed ID: 29606144
[TBL] [Abstract][Full Text] [Related]
14. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.
Mang'era CM; Mbai FN; Omedo IA; Mireji PO; Omar SA
Acta Trop; 2012 Sep; 123(3):202-7. PubMed ID: 22641431
[TBL] [Abstract][Full Text] [Related]
15. Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
Fu J; Jia Q; Zhou H; Zhang L; Wang S; Liang P; Lv Y; Han S
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122469. PubMed ID: 33310480
[TBL] [Abstract][Full Text] [Related]
16. Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.
Yang H; Yang Y; Yang P; Li X; Gao B; Zhang Z; Yang Z; Cui L
Acta Trop; 2008 Oct; 108(1):44-9. PubMed ID: 18822265
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates.
Srivastava HC; Yadav RS; Joshi H; Valecha N; Mallick PK; Prajapati SK; Dash AP
Ann Trop Med Parasitol; 2008 Sep; 102(6):471-80. PubMed ID: 18782486
[TBL] [Abstract][Full Text] [Related]
18. Effect of liquiritigenin on chloroquine accumulation in digestive vacuole leading to apoptosis-like death of chloroquine-resistant P. falciparum.
Kumar S; Kapkoti DS; Mina PR; Gupta M; Kumar R; Kumar P; Pathak P; Bhakuni RS; Rout P; Pal A; Darokar MP
Phytomedicine; 2023 Jun; 114():154738. PubMed ID: 36940579
[TBL] [Abstract][Full Text] [Related]
19. Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy.
Summers RL; Martin RE
Virulence; 2010; 1(4):304-8. PubMed ID: 21178460
[TBL] [Abstract][Full Text] [Related]
20. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
